No abstract available
Keywords:
COVID-19; adherence; biological disease-modifying antirheumatic drugs; methotrexate; pandemic; rheumatoid arthritis.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antirheumatic Agents* / therapeutic use
-
Arthritis, Rheumatoid* / drug therapy
-
Arthritis, Rheumatoid* / epidemiology
-
COVID-19*
-
Cross-Sectional Studies
-
Humans
-
Japan / epidemiology
-
Methotrexate / therapeutic use
-
Pandemics
-
Treatment Adherence and Compliance
Substances
-
Antirheumatic Agents
-
Methotrexate